Neuroimaging clinics of North America
-
Neuroimaging Clin. N. Am. · Nov 2003
ReviewImaging the epileptic brain with positron emission tomography.
Positron emission tomography (PET) has an established role in the noninvasive localization of epileptic foci during presurgical evaluation. [18F]fluorodeoxyglucose (FDG) PET is able to lateralize and regionalize potentially epileptogenic regions in patients who have normal MR imaging and is also useful in the evaluation of various childhood epilepsy syndromes, including cryptogenic infantile spasms and early Rasmussen's syndrome. Novel PET tracers that were developed to image neurotransmission related to gamma-aminobutyric acid (GABA) [with [11C]flumazenil] and serotonin-mediated [with alpha-[11C]methyl-L-tryptophan (AMT)] function provide increased specificity for epileptogenic cortex and are particularly useful when FDG PET shows large abnormalities of glucose metabolism. Detailed comparisons of PET abnormalities with intracranial electroencephalographic findings also improve our understanding of the pathophysiology of human epilepsy.
-
This article described basic ideas and concepts that are related to the performance and analysis of dynamic tracer kinetic PET studies of brain. There are many aspects of these studies that require careful consideration, because there is always a compromise between accuracy and precision [101]. Important issues that were not discussed in this article include the appropriate use of anatomic information for the interpretation and analysis of the functional PET imaging data, ROI sampling, or parametric image generation; statistical analyses of ROI and parametric data; as well as steps involved in the evaluation of novel radiotracers and the identification of an analysis-of-choice or issues related to methodologic optimization. Fig. 5 is a summary diagram that links these ideas and provides a more complete picture of the multiple components that are involved in tracer kinetic PET imaging research.
-
Neuroimaging Clin. N. Am. · Aug 2003
ReviewNasopharynx: clinical, pathologic, and radiologic assessment.
NPC represents 0.2% of malignant disease in the white population but is more common in southern China, among Chinese in East Asia and the United [figure: see text] States, and in North Africa, including Saudi Arabia. NPC in these ethnic groups tends to manifest at a younger age. Undifferentiated carcinoma is the most common histopathologic type and is associated with EBV. ⋯ In addition, the metastatic lymph nodes in the neck reveal no specific imaging features that would allow differentiation from other lymph node metastases. They may be discrete, often multiple, and large and bulky displaying a variable degree of necrosis and enhancement following introduction of contrast material. Local recurrence manifests commonly within the first 2 to 3 years posttherapy and is optimally evaluated by MR imaging and PET scanning.
-
Benign odontogenic tumors are characterized by imaging findings of expansile growth and well-defined margins with smooth borders, and their appearance is very similar to that of odontogenic and nonodontogenic cysts. From the viewpoint of diagnostic imaging of odontogenic tumors, teeth are designed differently according to their origin from the apex or crown. Therefore, for differential diagnosis, it is necessary to select diagnostic methods that make it possible to evaluate these findings in detail. ⋯ MR imaging is effective in differentiating between tumors and cysts, evaluating the infiltration of malignant tumors in the jawbone and surrounding soft tissue, and detecting bone marrow changes of the jaw. Differentiation between tumors and cysts must be achieved by contrast-enhanced studies. Combining plain radiography with advanced imaging techniques, including CT and MR imaging, can improve the accuracy of diagnosing odontogenic tumors.
-
Neuroimaging Clin. N. Am. · Aug 2003
ReviewFibro-osseous and giant cell lesions, including brown tumor of the mandible, maxilla, and other craniofacial bones.
Fibro-osseous, osseous, cartilaginous, and giant cell lesions of the mandible, maxilla, and other craniofacial bones share overlapping clinical, radiologic, and pathologic features that may lead to diagnostic confusion and possible misdiagnosis. The value of combined clinical-radiologic-pathologic correlation in the diagnosis of these lesions is paramount to achieving the correct diagnosis with subsequent implementation of appropriate therapeutic intervention.